PP
PrairieView Partners’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 386 |
|
2025
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 381 |
|
2024
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 381 |
|
2024
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 403 |
|
2024
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 395 |
|
2024
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 374 |
|
2023
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 406 |
|
2023
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 454 |
|
2023
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 470 |
|
2023
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 474 |
|
2022
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 489 |
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 462 |
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 476 |
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 477 |
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 433 |
|
2021
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 384 |
|
2021
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 374 |
|
2021
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 372 |
|
2020
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 321 |
|
2020
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 315 |
|
2020
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 305 |
|
2020
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 300 |
|